FDA OKs First Drug for Liver Disease-Related Pruritus

(MedPage Today) — The FDA approved linerixibat (Lynavoy) as the first drug indicated for cholestatic pruritus stemming from primary biliary cholangitis (PBC), drugmaker GSK announced on Thursday.
PBC is a rare but serious autoimmune disease where…